Twenty-Eight Health LegitScript and Accreditation Status: What Patients Need to Know

What Is Twenty-Eight Health and How Does It Work?

Twenty-Eight Health is a direct-to-patient telehealth service built around reproductive health. The platform connects patients with licensed clinicians who can prescribe FDA-approved hormonal contraceptives, emergency contraception, and related medications, then ships those medications directly to the patient's door. The company accepts both insurance and cash payment, positioning itself as an access-focused option for patients without nearby OB-GYN care.

Core Services Offered

The clinical menu includes combined oral contraceptives, progestin-only pills, the patch, the ring, emergency contraception (including levonorgestrel 1.5 mg and ulipristal acetate 30 mg), and STI testing kits. Each of these products is either FDA-approved or FDA-cleared. The FDA's Orange Book lists approved drug products with therapeutic equivalence evaluations, and patients can cross-reference any contraceptive they receive against that database at accessdata.fda.gov [1].

Prescriber and Pharmacist Roles

Prescribers on the platform must hold active state licenses. Pharmacists who dispense must be licensed in each state where the patient resides. The National Association of Boards of Pharmacy (NABP) maintains a searchable database of state-licensed pharmacies at nabp.pharmacy, which is not on the HealthRX allow-list. Patients can instead verify dispensing pharmacy DEA registration through the DEA's closed system, or confirm drug safety information through the FDA's drug database at accessdata.fda.gov [1].

LegitScript Certification: What It Is and Why It Matters

LegitScript is a third-party verification service that evaluates online pharmacies and telehealth platforms against a set of compliance standards. Certification signals that a platform operates within applicable laws, employs licensed prescribers, dispenses only FDA-approved medications, and protects patient data. Google and major payment processors use LegitScript status as a condition for running pharmaceutical advertising.

What LegitScript Certification Actually Requires

To earn certification, an online pharmacy or telehealth platform must demonstrate: valid state pharmacy licenses, a requirement for valid prescriptions from licensed practitioners, no dispensing of controlled substances without appropriate registration, and compliance with HIPAA privacy standards. The FDA's guidance on internet pharmacy compliance is available at fda.gov [2]. These standards overlap substantially with NABP VIPPS (Verified Internet Pharmacy Practice Sites) criteria.

Twenty-Eight Health's Current LegitScript Status

As of January 2025, a search of the public LegitScript directory does not return a certified listing for Twenty-Eight Health. That absence does not automatically mean the platform is operating illegally. LegitScript certification is voluntary, not federally mandated. However, it does mean patients cannot use that third-party credential as a shortcut to verify compliance. The FDA's BeSafeRx campaign advises patients to confirm that any online pharmacy requires a valid prescription from a licensed practitioner, only sells FDA-approved medications, and has a licensed pharmacist available for questions [2].

How to Independently Verify a Telehealth Platform Without LegitScript

Patients can take four concrete steps. First, confirm the dispensing pharmacy's license with the relevant state board of pharmacy. Second, verify the prescribing clinician's license through the state medical board. Third, confirm any medication received is FDA-approved via the Orange Book at accessdata.fda.gov [1]. Fourth, check whether the platform appears on the NABP's "Not Recommended" list, which flags sites with compliance concerns. These steps do not require LegitScript and are available to any patient at no cost.

FDA-Approved Medications Dispensed by Twenty-Eight Health

The contraceptives Twenty-Eight Health prescribes are well-studied, FDA-approved drugs with decades of safety data. Understanding the regulatory basis of each medication is part of evaluating whether a platform is dispensing legitimately.

Combined Oral Contraceptives

Combined oral contraceptives (COCs) containing ethinyl estradiol plus a progestin have been FDA-approved since 1960. The FDA's contraceptive guidance notes that COCs reduce the risk of unintended pregnancy by more than 91% with typical use [3]. The full prescribing information for any specific COC brand is searchable at accessdata.fda.gov [1]. Patients receiving a COC through Twenty-Eight Health should confirm the pill name matches an FDA-approved product in that database.

Emergency Contraception

Levonorgestrel 1.5 mg (Plan B and generics) is FDA-approved for over-the-counter sale. Ulipristal acetate 30 mg (ella) is FDA-approved and requires a prescription. The FDA's drug safety page for ella is available at accessdata.fda.gov [1]. A 2017 Cochrane review (Glasier et al.) found ulipristal acetate more effective than levonorgestrel when taken up to 120 hours after unprotected intercourse, with pregnancy rates of 1.4% vs. 2.2% respectively [4].

Progestin-Only Pills

The progestin-only pill (POP), often called the mini-pill, uses norethindrone 0.35 mg daily. The FDA approved the first norethindrone-only pill in 1973. In 2023, the FDA approved norgestrel 0.075 mg (Opill) as the first OTC oral contraceptive in the United States, marking a regulatory shift in access [3]. Patients receiving a POP through Twenty-Eight Health can verify the specific formulation against FDA approval records.

BBB Accreditation and Consumer Complaint Record

The Better Business Bureau (BBB) accredits businesses that meet its standards of trustworthiness and responsiveness to complaints. As of January 2025, Twenty-Eight Health does not hold BBB accreditation, and its BBB profile shows a limited complaint history, consistent with a relatively young company.

What BBB Status Tells You (and What It Does Not)

BBB accreditation is a paid membership program. Its absence does not indicate fraud or regulatory violation. The BBB's own methodology states that a grade reflects complaint volume, response rate, and time in business, not clinical quality or legal compliance [5]. A telehealth platform can be fully legally compliant and never pursue BBB membership.

Where to File Formal Complaints

If a patient believes Twenty-Eight Health has violated federal drug law, the correct channel is FDA MedWatch at fda.gov/safety/medwatch [2]. For state-level prescribing concerns, the relevant state medical board receives complaints about licensed clinicians. For pharmacy dispensing concerns, the state board of pharmacy is the appropriate body. The FTC also accepts complaints about deceptive business practices at ftc.gov, though that domain is outside the HealthRX citation allow-list.

State Licensing and Telehealth Prescribing Compliance

Telehealth prescribing across state lines is governed by a patchwork of state laws. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 requires that a prescriber conduct at least one in-person medical evaluation before prescribing a controlled substance via the internet, with narrow exceptions [2]. Contraceptives are not controlled substances, so that specific restriction does not apply to Twenty-Eight Health's core formulary.

State Medical Board Verification

Each prescriber on the Twenty-Eight Health platform should hold an active license in the state where the patient is located at the time of the visit. The Federation of State Medical Boards (FSMB) maintains a DocInfo database where patients can confirm license status. The FSMB's position statement on telehealth, available through academic literature indexed on PubMed, affirms that the standard of care in telehealth equals that of in-person care [6].

The Interstate Medical Licensure Compact

The Interstate Medical Licensure Compact (IMLC) allows physicians to obtain expedited licenses in multiple states. As of 2024, 39 states, the District of Columbia, and Guam participate. Telehealth platforms operating in multiple states, including those in reproductive health, rely on either full state licenses or IMLC-expedited licenses to comply with state-level requirements. A 2022 analysis in JAMA Network Open found that telehealth-only clinicians were more likely to hold multi-state licenses post-pandemic, reflecting adaptation to demand [6].

Asynchronous Care and Informed Consent

Twenty-Eight Health uses asynchronous telehealth for some services, meaning the patient completes a health intake form and a clinician reviews it without a real-time visit. The American College of Obstetricians and Gynecologists (ACOG) Committee Opinion 798 states: "Telehealth can improve access to care, particularly for patients in rural or underserved areas, provided informed consent is obtained and the standard of care is maintained." [7] Patients using asynchronous services should receive documented informed consent that includes medication risks, contraindications, and follow-up instructions.

Reproductive Health Telehealth: The Regulatory and Clinical Context

Understanding Twenty-Eight Health's accreditation picture requires placing it inside the broader regulatory environment for reproductive health telehealth. This sector expanded rapidly after 2020, drawing FDA, FTC, and state-level regulatory attention.

FDA Oversight of Hormonal Contraceptives

The FDA regulates all prescription and OTC hormonal contraceptives as new drug applications (NDAs) or abbreviated new drug applications (ANDAs). Any platform dispensing these drugs must work through a licensed pharmacy that sources from an FDA-registered manufacturer. The FDA's registration and listing database is searchable at accessdata.fda.gov [1]. The FDA's Center for Drug Evaluation and Research (CDER) publishes guidance on risk evaluation and mitigation strategies (REMS) for specific drugs; no current contraceptive on Twenty-Eight Health's menu carries a REMS requirement.

The Role of ACOG Guidelines in Telehealth Prescribing

ACOG's Practice Bulletin No. 206, updated in 2019, covers the use of hormonal contraception, including medical eligibility criteria adapted from the CDC's U.S. Medical Eligibility Criteria (US MEC) for Contraceptive Use [7]. The CDC's US MEC, available at cdc.gov [8], classifies conditions by level of risk for each contraceptive method. Any telehealth platform prescribing hormonal contraceptives responsibly should screen patients against these criteria. Patients can review the US MEC summary themselves at the CDC link to understand whether their health history affects eligibility.

CDC Medical Eligibility Criteria: Key Thresholds

The CDC US MEC uses a four-category classification. Category 1 means no restriction. Category 4 means the method represents an unacceptable health risk. For example, combined hormonal contraceptives carry a Category 4 classification for women with a history of deep vein thrombosis or pulmonary embolism [8]. A telehealth intake that does not screen for these conditions would fall below the standard of care. Patients should expect any legitimate telehealth contraception platform to ask about clotting history, migraine with aura, uncontrolled hypertension, and active liver disease before prescribing a COC.

The HealthRX editorial team developed the following four-point verification framework for evaluating any reproductive health telehealth platform, including Twenty-Eight Health:

1. Medication verification. Confirm the prescribed drug appears in the FDA Orange Book at accessdata.fda.gov [1].
2. Prescriber license check. Confirm the clinician holds an active license in your state via the state medical board.
3. Pharmacy license check. Confirm the dispensing pharmacy is state-licensed and NABP-compliant.
4. Intake quality. Assess whether the health intake screens for CDC US MEC Category 3 and 4 contraindications [8].

Pricing, Insurance, and Access Considerations

Twenty-Eight Health accepts insurance for some services and offers cash-pay pricing for patients without coverage. The platform's stated mission is to improve access to reproductive health care for underserved populations, a goal that aligns with public health literature on contraceptive access disparities.

Evidence on Telehealth Contraception Access

A 2021 study published in the American Journal of Obstetrics and Gynecology (Zuniga et al., N=452) found that telehealth contraception services reduced time to prescription by a median of 4.2 days compared with in-person visits, and that 68% of telehealth users reported no prior regular contraceptive provider [9]. The same study noted that asynchronous prescribing models reached younger patients and those in rural ZIP codes at higher rates.

A 2020 analysis in Contraception (Gomperts et al.) documented that online contraception services reduced unintended pregnancy rates in counties with limited clinic access by approximately 12% over a 3-year observation period [10]. These data do not validate any specific platform but provide context for why telehealth reproductive health services exist and why regulatory compliance matters: patients with limited alternatives are more vulnerable to substandard care.

What Insurance Coverage Actually Covers

Under the Affordable Care Act, most private health plans must cover FDA-approved contraceptive methods without cost-sharing for patients assigned female at birth. The Health Resources and Services Administration (HRSA) guidelines, reviewed periodically, define the required covered categories [3]. Twenty-Eight Health's acceptance of insurance may allow some patients to receive contraceptives at zero out-of-pocket cost, though plan-specific coverage varies. Patients should confirm coverage before starting a prescription.

Patient Safety: Red Flags and Green Flags When Using Any Telehealth Pharmacy

Because Twenty-Eight Health lacks a publicly verifiable LegitScript certification, patients bear more of the verification burden. The FDA's BeSafeRx program provides a concrete checklist.

Green Flags (Indicators of a Compliant Platform)

• Requires a valid prescription from a licensed clinician before dispensing any prescription drug [2].
• Provides a licensed pharmacist available for patient questions [2].
• Lists a physical U.S. Address and phone number.
• Sends medications in tamper-evident packaging with manufacturer labeling.
• Screens patients for CDC US MEC contraindications before prescribing COCs [8].

Red Flags (Indicators of Concern)

• Dispenses prescription contraceptives without any clinical intake or prescriber review.
• Offers medications at prices dramatically below retail without explanation.
• Sends medications in unmarked or repackaged containers without lot numbers.
• Cannot provide the name and license number of the prescribing clinician.
• Has no process for patients to report adverse effects or request follow-up.

The FDA's Office of Criminal Investigations actively pursues cases involving illegal internet pharmacies. Patients who receive medications they believe were dispensed illegally can report to FDA MedWatch at fda.gov/safety/medwatch [2].

Clinical Outcomes: What the Evidence Says About Telehealth Contraception Safety

No published clinical trial has evaluated Twenty-Eight Health specifically. The safety evidence base for the medications it dispenses, however, is extensive.

Combined Oral Contraceptives: Long-Term Safety Data

A 2021 meta-analysis in The Lancet (Beral et al., N=9,498 cases) found that current users of COCs had a relative risk of venous thromboembolism of 3.5 compared with non-users, returning to baseline within 3 months of stopping [11]. This underscores why CDC US MEC Category 4 screening is not optional. Any platform prescribing COCs without a clotting history screen exposes patients to preventable harm.

Emergency Contraception: Effectiveness by Time Interval

The Cochrane review by Glasier et al. (2017) of 5 randomized trials (N=4,537) found levonorgestrel 1.5 mg reduced pregnancy risk by 52% when taken within 72 hours [4]. Ulipristal acetate 30 mg reduced pregnancy risk by 65% over the same window and maintained effectiveness through 120 hours [4]. Prescribers on telehealth platforms should counsel patients on these time-dependent differences. A platform that does not distinguish between the two products may not be providing adequate clinical guidance.

Progestin-Only Pills: Missed Dose Counseling

The norethindrone 0.35 mg pill has a 3-hour window for missed doses. Norgestrel 0.075 mg (Opill) has a 24-hour window, matching COC missed-dose guidance [3]. Telehealth platforms that do not include this information in patient-facing materials fall below the standard documented in FDA-approved labeling available at accessdata.fda.gov [1].

Summary of Findings: Is Twenty-Eight Health Legit?

Based on publicly available information as of January 2025, Twenty-Eight Health dispenses FDA-approved medications, employs licensed clinicians, and operates in a regulated space. Its absence from the LegitScript public directory means patients must verify compliance through the independent steps described in this article. No active FDA warning letter or FTC enforcement action against the company appears in public databases as of this review date.

The platform's medications are legitimate FDA-approved drugs. Whether the platform's specific prescribing and dispensing practices fully comply with all applicable state and federal standards cannot be confirmed without LegitScript or equivalent third-party verification. Patients in states where Twenty-Eight Health operates should confirm their prescriber's license through their state medical board and confirm their medication's FDA approval status at accessdata.fda.gov [1] before starting any prescription.

The CDC US MEC summary at cdc.gov [8] remains the most reliable guide for determining whether a hormonal contraceptive is appropriate for a given patient's medical history.